The groundbreaking therapy of this peptide represents a major development in the care of type 2 diabetes. Different to existing drugs, tirzepatide impacts two pathways – the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP) – providing improved sugar regulation and potential reduction in weight. Researchers are exploring its … Read More